• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

BELLUS Health Inc

+ Add to Watchlist

BHN:GR

0.756 EUR 0.024 3.08%

As of 02:02:33 ET on 07/31/2014.

Snapshot for BELLUS Health Inc (BHN)

Open: 0.756 Day's Range: 0.756 - 0.756 Volume: 6,500
Previous Close: 0.780 52wk Range: 0.205 - 1.000 1-Yr Rtn: +260.00%

Stock Chart for BHN

No chart data available.
  • BHN:GR 0.756
  • 1M
  • 1Y
0.780
Interactive BHN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BHN

Current P/E Ratio (ttm) -
Estimated P/E(12/2013) -
Relative P/E vs. DAX -
Earnings Per Share (CAD) (ttm) -
Est. EPS (CAD) (12/2013) -
Est. PEG Ratio -
Market Cap (M EUR) 35.85
Shares Outstanding (M) 47.43
30 Day Average Volume 5,374
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BHN

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for BHN

BELLUS Health Inc. develops and commercializes therapeutics for neurological disorders. The Company has products in clinical trials for AA amyloidosis, the treatment of Alzheimer's Disease, and for the prevention of hemorrhagic stroke caused by amyloid angiopathy.

Roberto BelliniPresident/CEODenis GarceauSenior VP:Drug Development
Francois DesjardinsVP:FinanceTony MatzouranisVP:Business Development
More Company Profile & Key Executives for BHN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil